Literature DB >> 6491656

Guanyl nucleotide and divalent cation regulation of cortical S2 serotonin receptors.

G Battaglia, M Shannon, M Titeler.   

Abstract

Computer-assisted quantitative analysis of radioligand binding to rat cortical S2 serotonin receptors indicates the existence of two affinity states of the same receptor population. Monophasic antagonist competition curves for [3H]ketanserin-labelled sites suggest a uniform population of receptors with one affinity state for antagonists. Biphasic competition curves of agonists suggest that agonists discriminate high- and low-agonist-affinity forms of the S2 receptors. The affinities of agonists for the high- and low-affinity states, and the apparent percentages of high agonist-affinity forms varies with different agonists. The guanine nucleotides GTP and guanyl-5'-imido-diphosphate [Gpp(NH)p], as well as divalent cations, modulate the proportion of the sites with high affinity for agonists as evidenced by their ability to shift the agonist competition curves for [3H]ketanserin-labelled S2 receptors. GTP and Gpp(NH)p effects appear to be agonist-specific, as they do not affect antagonist competition for [3H]ketanserin-labelled S2 receptors, or [3H]ketanserin binding to S2 receptors. ATP and ADP have little or no effect on the binding properties of S2 serotonin receptors, whereas GDP is less potent than GTP. The presence of these specific nucleotide effects are the first evidence suggesting involvement of a guanine nucleotide-binding protein in the mechanism of agonist interaction with the S2 serotonin receptor. In general, the binding properties of [3H]ketanserin-labelled S2 serotonin receptors strongly resemble those of adenylate-cyclase coupled receptors such as the beta-adrenergic, the alpha 2-receptor, and the D-2 dopamine receptor. This may indicate the S2 serotonin receptor is coupled to adenylate cyclase activity, through a GTP binding protein.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491656     DOI: 10.1111/j.1471-4159.1984.tb05375.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Molecular structural basis of ligand selectivity for 5-HT2 versus 5-HT1C cortical receptors.

Authors:  P A Pierce; J Y Kim; S J Peroutka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

2.  Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs.

Authors:  Anil Purohit; Carol Smith; Katharine Herrick-Davis; Milt Teitler
Journal:  Psychopharmacology (Berl)       Date:  2004-12-10       Impact factor: 4.530

3.  Increased uptake sites for serotonin and dopamine with decreased S2 serotonin receptors in microencephalic rat brain.

Authors:  M Watanabe; M Kinuya; G Mamiya; T Tatsunuma; M Nagayoshi; T Matsutani; Y Tsukada
Journal:  Neurochem Res       Date:  1990-10       Impact factor: 3.996

4.  Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice.

Authors:  John P Dougherty; Vincent J Aloyo
Journal:  Psychopharmacology (Berl)       Date:  2011-02-22       Impact factor: 4.530

5.  Enhanced 5-HT2C receptor signaling is associated with haloperidol-induced "early onset" vacuous chewing in rats: implications for antipsychotic drug therapy.

Authors:  William A Wolf; Gerald J Bieganski; Veronica Guillen; Laurence Mignon
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

6.  Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.

Authors:  P A Pierce; S J Peroutka
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion.

Authors:  J Ulrichsen; J S Partilla; E M Dax
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  [3H]ketanserin labels 5-HT2 receptors and alpha 1-adrenoceptors in human and pig brain membranes.

Authors:  D Hoyer; P Vos; A Closse; A Pazos; J M Palacios; H Davies
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

9.  Metal ion and guanine nucleotide modulations of agonist interaction in G-protein-coupled serotonin1A receptors from bovine hippocampus.

Authors:  K G Harikumar; A Chattopadhyay
Journal:  Cell Mol Neurobiol       Date:  1998-10       Impact factor: 5.046

10.  Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.

Authors:  M Titeler; R A Lyon; R A Glennon
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.